Contact
searchSearch
HMP Global

Respiratory Syncytial Virus Topic Center

Featured Article

News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Comorbidities Drive ICU Admission and Mortality in RSV and HMPV Among Older Adults
07/16/2025
Grace Taylor, MS, MA
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals...
07/16/2025
Pharmacy Learning Network
News
New RSV Vaccines Prove Effective in Older Veterans, VA Reports
07/08/2025
Grace Taylor, MS, MA
A study by the US Department of Veterans Affairs reveals that newly approved respiratory syncytial virus (RSV) vaccines significantly reduce infections and hospitalizations among veterans aged 60 and older.
A study by the US Department of Veterans Affairs reveals that newly approved respiratory syncytial virus (RSV) vaccines significantly reduce infections and hospitalizations among veterans aged 60 and older.
A study by the US Department of...
07/08/2025
Pharmacy Learning Network
News
RSV Vaccines Modestly Reduced Hospitalizations Among Older Adults in Local Study
06/16/2025
Grace Taylor, MS, MA
An analytical model study from King County, Washington, shows that respiratory syncytial virus (RSV) immunizations helped reduce hospitalizations among older adults during the 2023-2024 season.
An analytical model study from King County, Washington, shows that respiratory syncytial virus (RSV) immunizations helped reduce hospitalizations among older adults during the 2023-2024 season.
An analytical model study from...
06/16/2025
Pharmacy Learning Network
News
Multiple-Specimen Testing More Than Doubles RSV Detection in Hospitalized Adults
06/09/2025
Grace Taylor, MS, MA
The use of multiple specimen types more than doubles respiratory syncytial virus (RSV) detection rates in hospitalized adults compared to standard nasopharyngeal swabs, according to a study published in the Journal of Infectious Diseases.
The use of multiple specimen types more than doubles respiratory syncytial virus (RSV) detection rates in hospitalized adults compared to standard nasopharyngeal swabs, according to a study published in the Journal of Infectious Diseases.
The use of multiple specimen...
06/09/2025
Pharmacy Learning Network
News
Awareness and Access Gaps Hinder Uptake of RSV Vaccine Among Older Adults
05/20/2025
Grace Taylor, MS, MA
Despite the rollout of the first RSV vaccines for older adults, a new study finds that lack of awareness and access significantly limited uptake during the 2023-2024 season.
Despite the rollout of the first RSV vaccines for older adults, a new study finds that lack of awareness and access significantly limited uptake during the 2023-2024 season.
Despite the rollout of the first...
05/20/2025
Pharmacy Learning Network
News
RSV Vaccines Effective for Seniors With Small Increased Guillain-Barré Risk
05/13/2025
Grace Taylor, MS, MA
Research finds respiratory syncytial virus (RSV) vaccines offer strong protection for older adults, while highlighting a small but significant risk of Guillain-Barré syndrome.
Research finds respiratory syncytial virus (RSV) vaccines offer strong protection for older adults, while highlighting a small but significant risk of Guillain-Barré syndrome.
Research finds respiratory...
05/13/2025
Pharmacy Learning Network
News
Single-Dose RSV Vaccine Shows Sustained Protection in Older Adults
04/30/2025
Grace Taylor, MS, MA
A single dose of the RSVPreF3 OA vaccine provides lasting protection against RSV-related lung disease in older adults for up to three seasons, new trial results show.
A single dose of the RSVPreF3 OA vaccine provides lasting protection against RSV-related lung disease in older adults for up to three seasons, new trial results show.
A single dose of the RSVPreF3 OA...
04/30/2025
Pharmacy Learning Network
News
Self-Collected Oral-Nasal Swabs Fall Short for Detecting Influenza and RSV
04/29/2025
Grace Taylor, MS, MA
Self-swabbing for respiratory viruses may offer convenience but could come at the cost of missed diagnoses, a new study finds.
Self-swabbing for respiratory viruses may offer convenience but could come at the cost of missed diagnoses, a new study finds.
Self-swabbing for respiratory...
04/29/2025
Pharmacy Learning Network
News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
RSV Vaccine Demonstrates High Effectiveness in Preventing Severe Respiratory Disease in Older Adults
01/21/2025
Lisa Kuhns, PhD, MD
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo...
01/21/2025
Pharmacy Learning Network

Newsfeed

News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Comorbidities Drive ICU Admission and Mortality in RSV and HMPV Among Older Adults
07/16/2025
Grace Taylor, MS, MA
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals...
07/16/2025
Pharmacy Learning Network
News
New RSV Vaccines Prove Effective in Older Veterans, VA Reports
07/08/2025
Grace Taylor, MS, MA
A study by the US Department of Veterans Affairs reveals that newly approved respiratory syncytial virus (RSV) vaccines significantly reduce infections and hospitalizations among veterans aged 60 and older.
A study by the US Department of Veterans Affairs reveals that newly approved respiratory syncytial virus (RSV) vaccines significantly reduce infections and hospitalizations among veterans aged 60 and older.
A study by the US Department of...
07/08/2025
Pharmacy Learning Network
News
RSV Vaccines Modestly Reduced Hospitalizations Among Older Adults in Local Study
06/16/2025
Grace Taylor, MS, MA
An analytical model study from King County, Washington, shows that respiratory syncytial virus (RSV) immunizations helped reduce hospitalizations among older adults during the 2023-2024 season.
An analytical model study from King County, Washington, shows that respiratory syncytial virus (RSV) immunizations helped reduce hospitalizations among older adults during the 2023-2024 season.
An analytical model study from...
06/16/2025
Pharmacy Learning Network
News
Multiple-Specimen Testing More Than Doubles RSV Detection in Hospitalized Adults
06/09/2025
Grace Taylor, MS, MA
The use of multiple specimen types more than doubles respiratory syncytial virus (RSV) detection rates in hospitalized adults compared to standard nasopharyngeal swabs, according to a study published in the Journal of Infectious Diseases.
The use of multiple specimen types more than doubles respiratory syncytial virus (RSV) detection rates in hospitalized adults compared to standard nasopharyngeal swabs, according to a study published in the Journal of Infectious Diseases.
The use of multiple specimen...
06/09/2025
Pharmacy Learning Network
News
Awareness and Access Gaps Hinder Uptake of RSV Vaccine Among Older Adults
05/20/2025
Grace Taylor, MS, MA
Despite the rollout of the first RSV vaccines for older adults, a new study finds that lack of awareness and access significantly limited uptake during the 2023-2024 season.
Despite the rollout of the first RSV vaccines for older adults, a new study finds that lack of awareness and access significantly limited uptake during the 2023-2024 season.
Despite the rollout of the first...
05/20/2025
Pharmacy Learning Network
News
RSV Vaccines Effective for Seniors With Small Increased Guillain-Barré Risk
05/13/2025
Grace Taylor, MS, MA
Research finds respiratory syncytial virus (RSV) vaccines offer strong protection for older adults, while highlighting a small but significant risk of Guillain-Barré syndrome.
Research finds respiratory syncytial virus (RSV) vaccines offer strong protection for older adults, while highlighting a small but significant risk of Guillain-Barré syndrome.
Research finds respiratory...
05/13/2025
Pharmacy Learning Network
News
Single-Dose RSV Vaccine Shows Sustained Protection in Older Adults
04/30/2025
Grace Taylor, MS, MA
A single dose of the RSVPreF3 OA vaccine provides lasting protection against RSV-related lung disease in older adults for up to three seasons, new trial results show.
A single dose of the RSVPreF3 OA vaccine provides lasting protection against RSV-related lung disease in older adults for up to three seasons, new trial results show.
A single dose of the RSVPreF3 OA...
04/30/2025
Pharmacy Learning Network
News
Self-Collected Oral-Nasal Swabs Fall Short for Detecting Influenza and RSV
04/29/2025
Grace Taylor, MS, MA
Self-swabbing for respiratory viruses may offer convenience but could come at the cost of missed diagnoses, a new study finds.
Self-swabbing for respiratory viruses may offer convenience but could come at the cost of missed diagnoses, a new study finds.
Self-swabbing for respiratory...
04/29/2025
Pharmacy Learning Network
News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
RSV Vaccination Averts Thousands of Severe Outcomes in First Year of US Adult Use
09/26/2025
Hannah Musick
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus...
09/26/2025
Pharmacy Learning Network
News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use